Business Context and Reporting Period
Company: American Shared Hospital Services
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 1999
Business Overview: The Company transitioned its business model during the period. On November 13, 1998, it sold its diagnostic imaging services (MRI, CT, Ultrasound, Nuclear Medicine, Cardiac Catheterization) and the stock of CuraCare, Inc. to a third party. Current operations focus on providing Gamma Knife units to five medical centers in California, Texas, and Connecticut through its majority-owned subsidiary, GK Financing, LLC.
Key Financial Metrics
| Metric | Q1 1999 | Q1 1998 |
|---|---|---|
| Revenues (Medical Services) | $1,566,000 | $9,322,000 |
| Total Costs & Expenses | $1,152,000 | $9,112,000 |
| Net Income | $488,000 | $205,000 |
| Earnings Per Share (Basic) | $0.11 | $0.04 |
| Operating Margin | 70% | 26% |
| Cash & Cash Equivalents | $8,772,000 | $24,000 |
| Restricted Cash | $2,299,000 | N/A |
| Total Assets | $25,255,000 | N/A |
| Working Capital | $8,587,000 | N/A |
| Long-Term Debt | $9,504,000 | N/A |
Note: Q1 1998 cash flow data is provided in the statement of cash flows, but comparative balance sheet data for Q1 1998 is not included in the filing text.
Material Changes vs. Prior Period
- Revenue Decline: Medical services revenues decreased by $7,756,000 (83%) compared to Q1 1998. This is primarily due to the sale of the diagnostic imaging division. However, Gamma Knife revenues increased by $930,000 due to higher utilization and the addition of two new units.
- Cost Reduction: Total costs of operations decreased by $6,448,000. Significant reductions occurred in payroll ($1,947,000), maintenance ($1,397,000), depreciation ($1,073,000), and equipment rental ($938,000), all attributable to the divestiture of the imaging business.
- Profitability Improvement: Despite lower revenue, Net Income increased by $283,000 (138%). The operating margin expanded significantly from 26% in Q1 1998 to 70% in Q1 1999.
- Cash Flow: Net cash used in operating activities was $(868,000) in Q1 1999, compared to $3,290,000 provided in Q1 1998. The decrease was driven by a $1,745,000 reduction in accounts payable and accrued liabilities and a $1,192,000 payment of income taxes related to the sale.
- Share Repurchase: The Company used $792,000 in cash to repurchase common stock during the quarter.
Outlook, Risks, and Management Commentary
- Liquidity: Management believes the current cash position ($8.8M) and working capital ($8.6M) are adequate to service cash requirements for 1999. Cash is invested in overnight repurchase agreements and commercial paper.
- Year 2000 (Y2K) Compliance: The Company is downsizing computer operations and upgrading hardware/software to be Y2K compliant, with completion expected in Q2 1999 at a cost not exceeding $70,000. The Gamma Knife revenue source is Y2K compliant. The primary risk identified is if customer disbursement systems fail to be Y2K compliant, potentially impacting payments.
- Restricted Cash: $1,000,000 of restricted cash was held under the terms of the sale until April 15, 1999, and was released on April 16, 1999.
- Legal Proceedings: No material legal proceedings were reported.
Investor Verification Checklist
- Revenue Sustainability: Verify the utilization rates and contract terms for the five Gamma Knife units to ensure the 70% operating margin is sustainable without the former imaging business.
- Customer Y2K Status: Confirm the Y2K compliance status of the five medical center customers' disbursement systems to assess payment risk.
- Debt Obligations: Review the terms of the $9.5M long-term debt and capital lease obligations to ensure cash flow coverage remains adequate.
- Restricted Cash Release: Confirm the release of the $1,000,000 restricted cash on April 16, 1999, and its subsequent deployment.
- Share Count: Note the reduction in outstanding shares due to the $792,000 repurchase program and its impact on future earnings per share.